Observational Study to Assess the Safety of rhTNK-tPA (Mingfule®) vs. Rt-PA (Actilyse®) in Treating Acute Ischemic Stroke
Clinical trial NCT07519889 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07519889
- Sponsor
- CSPC Mingfule Pharmaceutical (Guangzhou) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-04-10
- Primary completion
- 2027-01-10
- Enrollment
- 4500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.